相关实验视频

Updated: Sep 18, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

合成,分子对接和生物评估的A环-碳素-维生素D类似物

Rocío Otero¹, Samuel Seoane², Xoán Fernández-Domínguez¹

¹Ignacio Ribas Research Laboratory, Department of Organic Chemistry, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.

Molecules (Basel, Switzerland)

|June 27, 2025

概括

研究人员用carborane单位合成了新的维生素D类似物. 这些化合物表现出与活性维生素D3相似的抗增殖和高血效应,但只有一个模拟物强烈激活CYP24A1基因表达.

科学领域:

药用化学医学化学
内分泌学在内分泌学.
分子生物学分子生物学

背景情况:

维生素D3的活性形式,1α,25-二氧维生素D3 (1,25D3),对于调节细胞增殖和分化至关重要.
为了实现选择性的治疗效果,已经合成了大量的1,25D3类似物.
维生素D结构的非传统修改正在探索新的药理性质.

研究的目的:

为了合成和描述新型的维生素D类型,将 орто-carborane单元纳入A环.
评估这些新类型的生物活性,作为维生素D受体 (VDR) 的激动剂.
为了比较它们的抗增殖和高血效应与母化合物1,25D3,并评估它们对CYP24A1基因表达的影响.

主要方法:

合成了两种新型维生素D类似物,其中有骨质碳改性.
在体外试验测试以确定VDR激动活性和抗增殖作用.
在小鼠体内研究以评估高血活性.
对CYP24A1mRNA表达水平的定量分析.

主要成果:

合成的类似物作为VDR激动剂,具有与1,25D3.3相比的抗增殖活性.
两种类型4和5都在小鼠中诱导了类似于1,25D3.3的高血效应.
只有化合物4和1,25D3显示出CYP24A1mRNA表达的强烈激活,而化合物5没有.

结论:

新型维生素D类似物与A环正态碳酸改性保持VDR激动性和抗增殖性.
这些类似物对CYP24A1基因表达的差异激活表明了不同的下游信号通路.
这些发现为维生素D类型的结构-活性关系及其潜在的治疗应用提供了洞察力.

关键词:

一个-环-碳化合物.生物活动是生物活动.停靠的对接方式综合合成是一种合成.维生素D3的类似物维生素D3的受体是维生素D3的受体.

更多相关视频

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

相关概念视频

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

The Equilibrium Binding Constant and Binding Strength

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium: